Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Free Cash Flow Generation Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Free Cash Flow Generation Index of 0.32x as of December 2025. Free cash flow of $13.27 Million represents 0% of operating cash flow ($41.05 Million). Explore Zhengye Biotechnology Holding Limited Or (ZYBT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhengye Biotechnology Holding Limited Ordinary Shares Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. For the full cash flow conversion analysis, see Zhengye Biotechnology Holding Limited Or cash conversion from operations.
Annual Free Cash Flow Generation for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year Free Cash Flow Generation Index for Zhengye Biotechnology Holding Limited Ordinary Shares. Check Zhengye Biotechnology Holding Limited Or total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | $13.27 Million | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.32x | $13.27 Million | $41.05 Million | $27.77 Million | ▼ -57.4% |
| 2023 | 0.76x | $36.58 Million | $48.18 Million | $11.60 Million | ▲ +231.7% |
| 2022 | -0.58x | $-9.99 Million | $17.34 Million | $27.33 Million | ▼ -439.0% |
| 2021 | 0.17x | $5.41 Million | $31.81 Million | $26.40 Million | — |